Retinitis Pigmentosa: Global Therapeutics Pipeline Analysis Report 2017 with jCyte, Dompe Farmaceutici, ProRetina Therapeutics and Recursion Pharmaceuticals Dominating – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Retinitis Pigmentosa Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designations, Collaborations, and Other Developments" report has been added to ResearchAndMarkets.com's offering. The study analyzed that the retinitis pigmentosa therapeutics pipeline comprises approximately 38 drug candidates in different stages of development. Orphan drug designations from the regulatory bodies such as Food and Drug Administration (FDA), European M